CTRI/2022/01/039756尚未招募未知
To study dickkopf 1 and neuregulin 1 as bio markers for dermal pigmentation activity in acquired dermal macular hyperpigmentation.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- PGIMER
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with untreated lesions of acquired dermal macular pigmentation of either sex with age >= 18 years who can give valid consent.
排除标准
- •Age <18 years.
- •2. Patients refusing consent.
- •3. Pregnant and lactating women.
- •4. Patients on treatment ( a wash off period of 12 weeks will be taken to include in the study)
研究者
相似试验
尚未招募
不适用
Establishment of new diagnostic Biomarker and Characterization of protective bone marrow niche in patients with multiple myelomaC90Multiple myeloma and malignant plasma cell neoplasmsDRKS00010830niversitätsklinikum Freiburg160
招募中
不适用
Development of biological markers for early diagnosis and target treatment of carcinogenic processes of digestive cancer (pancreatic cancer, biliary tract cancer, gallbladder cancer, etc.)KCT0006268Yonsei University Health System, Gangnam Severance Hospital3,000
已完成
不适用
Development of a new biomarker for the detection of colorectal cancer using plasma concentrations of amino acids and metabolitesColorectal CancerJPRN-UMIN000029920Kyorin University School of Medicine The Third Department of Internal Medicine400
已完成
不适用
Study for biomarkers and molecular pathophysiology of Myeloproliferative disorders with eosinophilia.Hypereosinophilic syndrome, chronic eosinophilic leukemia, idiopathic eosinophilia.JPRN-UMIN000009140Kobe University Medical School Hospital300
招募中
不适用
Study for biomarkers and molecular pathophysiology of depression diversityMajor depressive disorderJPRN-UMIN000007825Gunma University Graduate School of Medicine80